Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04041
Species: Homo sapiens
Position : chr10:63525013-63527013
Year: 2017
Title: ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  29326336
MONDO: MONDO:0004963
Tissue: blood / hematopoietic system
Tissue Ontology ID: UBERON:0000178
Cell Source: T-acute lymphoblastic leukemia (T-ALL)
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Endogenous enhancer perturbation; Disease-associated enhancer analysis
High Throughput Method: ChIA-PET
Low Throughput Method: CRISPR-Cas9 targeted editing/deletion
About Target Gene
Target gene : ARID5B
About TF
TF name : TAL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_03180 chr10:63525013-63527013 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_03181 chr10:63525013-63527013 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_03182 chr10:63525013-63527013 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_04096 chr10:63525013-63527013 blood T lymphoblast T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer